Internal: Archive

Infant drugs company struggles

This content was published on Nov 9, 2000 But the management said the figures were in line with expectations. The company has yet to launch its first product. It expects to begin selling the hypertension drug, Tracleer, in the second half of next year pending approval from the United States Food and Drug Administration. Actelion is listed on the high-tech SWX New Market…

Ciba to sell masterbatch business

This content was published on Nov 9, 2000 Ciba, Switzerland’s number two producer of specialty chemicals, gave no financial terms for the transaction, which depends on the fulfilment of closing conditions and approval from the regulatory authorities. “The planned divestment of the masterbatch business will further strengthen Ciba’s focus on its core businesses,” said a company statement. Megides, which specialises in compounds and…

Irish company cements hold in Switzerland

This content was published on Nov 9, 2000 CRH is paying SFr646 million ($364 million) for the company. “Jura’s strong market positions in core CRH business sectors will allow us to benefit fully from the programme of major infrastructure projects in Switzerland which is set to underpin increasing demand for our products,” said CRH head, Liam O’Mahoney. Jura is Switzerland’s second biggest cement…

Stars’ bank details put on show

This content was published on Nov 9, 2000 Some famous account holders at Switzerland’s second largest bank had their account numbers, addresses and details of money transfers splashed across a publicly accessible website. Among those affected were the British actor, Roger Moore, the German pop star, Udo Jürgens, and the Swiss entertainer, DJ Bobo. The bank said the problem had been caused by…

Swiss ban blood donors from Britain after BSE scare

This content was published on Nov 8, 2000 From the beginning of 2001, anyone who has stayed longer than six months in Britain will not be accepted as a blood donor, Weltwoche reported on Wednesday. “It is a purely preventative measure,” Weltwoche quoted Guy Levy, the head of blood donation centre for the Swiss Red Cross, as saying. The decision was taken last…

CERN shuts down machine used to explore origins of the universe

This content was published on Nov 8, 2000 In a statement on Wednesday, the director-general, Luciano Maiani, said the Large Electron-Proton Collider (LEP) had been switched off “for the last time”. The announcement comes less than a week after the LEP was shut down after 11 years of service. The machine had been used to chase an elusive subatomic particle known as the…

Ecology professor wins prestigious prize

This content was published on Nov 8, 2000 Keller will receive the prize, worth SFr100,000 ($56,500), at a ceremony in Bern next January. The 39-year-old director of Lausanne’s Institute for Ecology has won respect in the scientific world for his research on ant colonies. His observations enabled him to show that colonies of ants are not always as efficient and harmonious as was…

Bern leads way in gene therapy for lung cancer

This content was published on Nov 8, 2000 The therapy was first developed at the University of Texas’ MD Anderson medical centre, and is being taking a step further in Bern and Barcelona. Healthy cells are programmed to die naturally, but thoracic oncologists – lung cancer specialists – have noticed a common phenomenon in tumours: gene mutation. Rather than dying, the mutant version…

US election jitters leaves market nervous

This content was published on Nov 8, 2000 Traders said there was unlikely to be much change on the markets until the outcome of a vote recount in the state of Florida, which will determine who wins the US election. “During the night we saw the dollar go down when news came out that Al Gore would make it,” said Marcus Allenspach, economist…

Swissmetal back on track

This content was published on Nov 8, 2000 Orders were swollen by increased demand from the domestic market as well as France, Italy, the United States and the Far East. The German market remains more subdued. The company’s head, Nadine Minnerath, has also been outlining the group’s new strategy. Swissmetal will in future focus on its core activities. The restructuring will cost 30…

Internal: Archive

Popular Stories

Most Discussed

Internal: Archive

More

Infant drugs company struggles

More

Ciba to sell masterbatch business

More

Irish company cements hold in Switzerland

More

Stars’ bank details put on show

More

Swiss ban blood donors from Britain after BSE scare

More

CERN shuts down machine used to explore origins of the universe

More

Ecology professor wins prestigious prize

More

Bern leads way in gene therapy for lung cancer

More

US election jitters leaves market nervous

More

Swissmetal back on track

Popular Stories

Most Discussed